TD-1058
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Theravance Biopharma
Overview
TD-1058 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
TD-1058 clinical trials
Explore related
Medical disclaimer. This page summarizes research about TD-1058 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.